Skip to Primary Navigation

Skip to main content

CMS ends Medicaid and CHIP funding for pediatric gender‑related procedures

A photo of a trans woman in a white coat and hat holding up a sign reading "Trans Health Care Saves Lives" at a rally.
Photo: Kevin Dietsch/Getty Images

Kevin Kinsella

1 min read
Click to share on Facebook (Opens in new window/tab) Click to share on X (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

New CMS rule bars federal dollars from covering puberty blockers, hormones, and surgeries for minors, citing safety concerns and insufficient evidence.

The Centers for Medicare & Medicaid Services (CMS) has finalized a rule prohibiting the use of federal Medicaid and Children’s Health Insurance Program (CHIP) funds for gender‑related medical procedures in children and youth.

According to CMS, the decision reflects a reassessment of available evidence, concluding that interventions such

, , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience